This study highlights the therapeutic potential of T. siliquosa root extract as a natural and multi-compound agent capable of targeting cyclin-dependent kinases CDK4 and CDK6, which are key drivers of cell cycle progression in various cancers. This evidence concerns the gene CDK4 and cancer.